To our knowledge, the possible link between MeCP2, nucleolin levels, and mTOR–P70S6K pathway in RTT and other MeCP2-associated neurological disorders (i.e., MDS) is a novel concept that is being reported. This evidence concerns the gene MECP2 and nervous system disorder.